Chemokines in liver inflammation and fibrosis

HE Wasmuth, F Tacke, C Trautwein - Seminars in liver disease, 2010 - thieme-connect.com
Chemokines are a class of small chemotactic molecules with cytokine-like functions, which
are well known to orchestrate inflammatory responses within different organs. Overall, more …

[HTML][HTML] Host proteins involved in HIV infection: new therapeutic targets

N Arhel, F Kirchhoff - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
Current treatment of HIV/AIDS consists of a combination of three to five agents targeting
different viral proteins, ie the reverse transcriptase, protease, integrase and envelope, and …

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

KS Rogacev, S Seiler, AM Zawada… - European heart …, 2011 - academic.oup.com
Aims Patients with chronic kidney disease (CKD) pose a worldwide growing burden to
health care systems due to accelerated atherosclerosis and subsequent high cardiovascular …

[HTML][HTML] Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines

AA Kan, W de Jager, M de Wit, C Heijnen… - Journal of …, 2012 - Springer
Mesial temporal lobe epilepsy (mTLE) is a chronic and often treatment-refractory brain
disorder characterized by recurrent seizures originating from the hippocampus. The …

[HTML][HTML] Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers

M Wild, D Karner, J Eickhoff, S Wagner, J Kicuntod… - Pharmaceutics, 2023 - mdpi.com
Despite the availability of currently approved antiviral drugs, infections with human
cytomegalovirus (HCMV) still cause clinically challenging, sometimes life-threatening …

CCR6 as a possible therapeutic target in psoriasis

MN Hedrick, AS Lonsdorf, ST Hwang… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Psoriasis is a common, chronic autoimmune disease of the skin.
Despite a number of effective treatments, new therapies are needed with enhanced efficacy …

[HTML][HTML] Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution

S Yadla, PM Jabbour, R Shenkar, C Shi… - Neurosurgical …, 2010 - thejns.org
Tremendous insight into the molecular and genetic pathogenesis of cerebral cavernous
malformations (CCMs) has been gained over the past 2 decades. This includes the …

[HTML][HTML] Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication

BA Desimmie, M Humbert, E Lescrinier, J Hendrix… - Molecular Therapy, 2012 - cell.com
The interaction between the human immunodeficiency virus (HIV) integrase (IN) and its
cellular cofactor lens epithelium-derived growth factor (LEDGF/p75) is crucial for HIV …

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor

RM Mosi, V Anastassova, J Cox, MC Darkes… - Biochemical …, 2012 - Elsevier
In order to enter and infect human cells HIV must bind to CD4 in addition to either the
CXCR4 or the CCR5 chemokine receptor. AMD11070 was the first orally available small …

Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide

WG Forssmann, YH The, M Stoll, K Adermann… - Science translational …, 2010 - science.org
To infect host cells, most enveloped viruses must insert a hydrophobic fusion peptide into
the host cell membrane. Thus, fusion peptides may be valuable targets for developing drugs …